FDA approves BESREMi for adults with essential thrombocythemia, offering a new treatment option for people living with this ...
Morning Overview on MSN
A newly approved protein-shredding drug gives myeloma patients another option
A newly approved cancer drug takes an unusual approach to treating multiple myeloma: instead of blocking a harmful protein, ...
A new study shows that epitranscriptomics, or chemical regulation of gene expression at the RNA level, determines whether ...
Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...
These are heady days for PharmaEssentia, a biotech that got its start 23 years ago in Taiwan, went public 10 years later and ...
Juelz Bogan stepped up to save his 19-month-old brother, Jahseh, who was diagnosed with a rare childhood leukemia.
The young boy was diagnosed with idiopathic multicentric Castleman disease — a rare immune system disorder that causes lymph ...
The Small Plasma Cell Clone Behind a Big Multisystem Disease / cancer, Castleman Disease, Hematology, OncoDaily, Oncology, ...
Anti-CD7 CAR T-Cell Therapy Shows Promising CNS Activity in Relapsed or Refractory T-ALL/LBL / Anti-CD7 CAR T, cancer, CAR ...
CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted ...
Trust Freddy Herald Correspondent FOR decades, a bone marrow transplant diagnosis in Zimbabwe meant starting a GoFundMe, booking a flight to India or South Africa, and praying that enough money came ...
In their quest to understand how cancers take root, grow and spread, scientists have for the past half-century explored the genetic aberrations and microenvironmental peculiarities of tumors and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results